Sat, May 15, 2010
Fri, May 14, 2010
Thu, May 13, 2010
Wed, May 12, 2010
[ Wed, May 12th 2010 ] - Market Wire
ENVIROTEK Becomes "SUFFER"
Tue, May 11, 2010
Mon, May 10, 2010
Sun, May 9, 2010
Sat, May 8, 2010
Fri, May 7, 2010
Thu, May 6, 2010
Mon, January 11, 2010
Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010
Mon, January 4, 2010
[ Mon, Jan 04th 2010 ] - Market Wire
Cordani Becomes CIGNA CEO

Peregrine Pharmaceuticals to Present at the Rodman & Renshaw Sixth Annual Global Investment Conference


//health-fitness.news-articles.net/content/2010/ .. w-sixth-annual-global-investment-conference.html
Published in Health and Fitness on Monday, May 10th 2010 at 6:10 GMT by Market Wire   Print publication without navigation


TUSTIN, CA--(Marketwire - May 10, 2010) - Peregrine Pharmaceuticals, Inc. (NASDAQ: [ PPHM ]), a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, today announced it will present at the Rodman & Renshaw Sixth Annual Global Investment Conference in London on Tuesday, May 18, 2010 at 10:40 am BST (5:40 am EDT). The conference will be held at the Grosvenor House Hotel in London, UK.

A live webcast of the company's presentation will be available in the Investors section of Peregrine's website at [ http://www.peregrineinc.com ]. A replay will be available on the Peregrine website and will be archived for 30 days.

For more information about this conference, please visit:
[ http://www.rodmanandrenshaw.com/conferences?id=44 ].

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in cancer and hepatitis C virus infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. ([ www.avidbio.com ]), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at [ www.peregrineinc.com ].


Publication Contributing Sources